Indivior (GB:INDV) has released an update.
Indivior PLC has announced the release of its year-to-date and third-quarter results for 2024, scheduled for October 24th, with a live webcast presentation by CEO Mark Crossley and the leadership team to follow. The results and webcast will be accessible via the company’s website, with options for telephonic access to the presentation. Indivior specializes in pharmaceuticals for treating substance use disorders and serious mental illnesses, with a mission to provide evidence-based treatments globally.
For further insights into GB:INDV stock, check out TipRanks’ Stock Analysis page.
